BioNeutral Announces U.S. Sales Representation Agreement With ProSell for Industrial Markets
December 19 2013 - 8:30AM
Marketwired
BioNeutral Announces U.S. Sales Representation Agreement With
ProSell for Industrial Markets
NEWARK, NJ--(Marketwired - Dec 19, 2013) - BioNeutral Group,
Inc. (OTCQB: BONU) (OTCBB: BONU) today announced that it has
entered into a Partnership Agreement with ProSell Sales
Representatives (ProSell), a national sales agency representing
products and services of high quality building products and outdoor
consumer goods.
The new agreement provides that ProSell will utilize its
national sales force to represent our YGIENE™ 206
Sporicide/Sterilant/Disinfectant to industrial, facility
maintenance and building trade distributors and their customers
seeking microbial remediation of surfaces. ProSell will market
BioNeutral's broad portfolio of YGIENE™ and OGIENE™ products.
Kerston Russell, Managing Partner for ProSell commented "ProSell
has embraced BioNeutral and, in particular, YGIENE 206 as a
superior solution for the distributors and end users within the
Industrial markets we call upon. After working with YGIENE™ for a
number of months we have determined that YGIENE™ is best
positioned, in the markets we serve, by emphasizing and focusing on
its mold killing capabilities. As we have intensified our
efforts in this direction we have found that YGIENE™ has proven to
be an exceptional product with no equal in the market
place. By focusing on the mold killing strengths we have begun
to see tremendous success in placing the product with some major
distributors. As a professional sales organization, the
representatives of ProSell have embraced this product and made it
our number one product offering. We feel very privileged to be
representing BioNeutral and selling the YGIENE™ and OGIENE™ product
lines."
"BioNeutral is developing and implementing market specific
channel strategies. This partnership will be the focal point of our
penetration into the Industrial, construction, facility maintenance
and mold remediation marketplace. This strategic agreement will
exponentially expand our reach with a well-connected sales
organization providing extensive coverage in one of the largest
market segments for our BioNeutral products," stated Ray Dunning,
Senior Vice President of Sales for BioNeutral Group, Inc. "The
ProSell Sales Team regularly calls on 1,200 to 1,500
customers/distributors each and every week. We are very excited to
have this group of professionals bringing YGIENE 206 to a
marketplace demanding the most effective solution for mold
remediation."
About ProSell Sales Representatives
Headquartered in Mundelein, IL, ProSell is a professional sales
group with a national reach focused on bringing value added
solutions to the facility maintenance, construction and building
industries nationwide. The product families that ProSell represents
are critical to protecting and maintaining both the interiors and
exteriors of all types of facilities, buildings, institutions and
structures throughout the United States. Find ProSell online at
http://www.prosellreps.com.
About BioNeutral Group, Inc.
Headquartered in Newark, New Jersey, BioNeutral Group, Inc., is
a specialty technology-based life-science company that has
developed a technology platform that neutralizes harmful
environmental contaminants, toxins and dangerous micro-organisms
including bacteria, viruses, mold, fungi and spores. BioNeutral's
products, YGIENE™ and OGIENE™, kill germs and clean surfaces with a
dramatic increase in speed and power over their rivals in the
marketplace. BioNeutral's proprietary platform technology has been
proven effective in surface, water and airborne applications. Its
antimicrobial line of products under the YGIENE™ brand have been
approved by the EPA for sale in the United States and has
previously been approved for sale in Germany and it is also
permitted to be sold in the UK, France and Sweden. For more
information on BioNeutral, including a listing of company products,
leadership and background please visit www.bioneutral.com.
Find us on Facebook:
http://www.facebook.com/pages/BioNeutral-Group/149109938452393
Follow us on Twitter: http://twitter.com/bioneutralgroup
Forward-Looking Statements: This release contains
certain "forward-looking statements" relating to the business of
the Company and its subsidiary companies. These forward-looking
statements are often identified by the use of forward-looking
terminology such as "believes," "expects" or similar expressions.
Such forward-looking statements involve known and unknown risks and
uncertainties that may cause actual results to be materially
different from those described herein as anticipated, believed,
estimated or expected. Investors should not place undue reliance on
these forward-looking statements, which speak only as of the date
of this press release. The Company's actual results could differ
materially from those anticipated in these forward-looking
statements as a result of a variety of factors, including those
described in the Company's filings with the Securities and Exchange
Commission. BioNeutral routinely tests its formulations against
those of its competitors. The results are published to let
shareholders know how the Company's technology compares with known
formulations in the market place. Any product claim for
antimicrobial activity requires approval from the EPA or FDA,
depending upon where and how the formulations are used. The EPA has
approved and registered the Company's data and findings specific to
Ygiene-206. BioNeutral's antimicrobial formulations will be
marketed under the brand name Ygiene® and are available for sale in
the United States.
CONTACT: FOR THE COMPANY: Mark Lowenthal CEO BioNeutral Group,
Inc. +1-973-577-8003